TY  - GEN
AU  - Murphy,G P
AU  - Tjoa,B A
AU  - Simmons,S J
AU  - Jarisch,J
AU  - Bowes,V A
AU  - Ragde,H
AU  - Rogers,M
AU  - Elgamal,A
AU  - Kenny,G M
AU  - Cobb,O E
AU  - Ireton,R C
AU  - Troychak,M J
AU  - Salgaller,M L
AU  - Boynton,A L
TI  - Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
SN  - 0270-4137
PY  - 1999///0223
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antigens, Neoplasm
KW  - administration & dosage
KW  - Antigens, Surface
KW  - Bone Neoplasms
KW  - diagnostic imaging
KW  - Cancer Vaccines
KW  - Carboxypeptidases
KW  - Dendritic Cells
KW  - Glutamate Carboxypeptidase II
KW  - HLA-A2 Antigen
KW  - Hormones
KW  - therapeutic use
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Radionuclide Imaging
KW  - Treatment Outcome
KW  - Vaccines, Synthetic
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/(sici)1097-0045(19990101)38:1<73::aid-pros9>3.0.co;2-v
ER  -